Home
Live Updates
Unicycive Therapeutics Provides Regulatory Update on : vimarsana.com
Unicycive Therapeutics Provides Regulatory Update on
LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...
Related Keywords
United States ,
Shalabh Gupta ,
Unicycive Therapeutics Inc ,
Reason Research ,
Company New Drug Application ,
Drug Administration ,
Exchange Commission ,
Nasdaq ,
Company Or Unicycive ,
Shire International Licensing ,
New Drug Application ,
Reference Listed Drug ,
End Stage Renal Disease ,
Lanthanum Dioxycarbonate ,
Private Securities Litigation Reform Act ,
Risk Factor ,
Annual Report ,
Nasdaq Uncy ,
Unicycive Therapeutics ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.